IVIG Dose Calculator (by Age & Weight)

Calculate accurate IVIG doses for patients with our free tool. Learn how proper dosing impacts treatment efficacy and safety in immunotherapy.

Check More Free Tools:

a red blood cell in a blood vessel
a red blood cell in a blood vessel
woman sitting on white bed while stretching
woman sitting on white bed while stretching

Free IVIG Dose Calculator - Personalized Immunoglobulin Therapy Planning

Intravenous Immunoglobulin (IVIG) therapy is a critical biological treatment used to manage immune-mediated disorders. Derived from pooled human plasma, IVIG contains concentrated antibodies that modulate immune responses, combat infections, and reduce inflammation. Precise dosing is paramount—too little may be ineffective, while too much increases risks of severe side effects. This comprehensive guide explores IVIG therapy, its applications, and how our IVIG Dose Calculator ensures optimal treatment planning.

What is IVIG?

IVIG is a sterile solution of immunoglobulin G (IgG) antibodies extracted from thousands of healthy donors. It works through multiple mechanisms:

  • Neutralizing pathogens (viruses, bacteria)

  • Blocking autoimmune antibodies

  • Regulating inflammatory cytokines

  • Preventing immune cell activation

Key Components:

ComponentFunctionIgG (95%)Primary therapeutic antibodiesIgA/IgMTrace amounts; may trigger reactionsStabilizersSugars (sucrose, maltose) prevent aggregation

Conditions Requiring IVIG Therapy

1. Primary Immunodeficiencies

  • X-linked agammaglobulinemia

  • Common Variable Immunodeficiency (CVID)

  • Severe Combined Immunodeficiency (SCID)

2. Neurological Disorders

  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Guillain-Barré Syndrome (GBS)

  • Myasthenia Gravis

3. Hematological Conditions

  • Immune Thrombocytopenic Purpura (ITP)

  • Kawasaki Disease

  • Autoimmune Hemolytic Anemia

4. Autoimmune & Inflammatory Diseases

  • Systemic Lupus Erythematosus (SLE)

  • Dermatomyositis

  • Rheumatoid Arthritis (refractory cases)

Symptoms Necessitating IVIG

IVIG is indicated when patients exhibit:

  • Recurrent bacterial infections (pneumonia, sinusitis)

  • Unexplained bruising/bleeding (low platelets in ITP)

  • Muscle weakness (CIDP, myasthenia gravis)

  • Chronic fatigue and unremitting inflammation

Diagnostic Procedures

Before initiating IVIG, clinicians conduct:

  1. Immunological Testing:

    • Serum IgG/IgA/IgM levels

    • Vaccine response panels

  2. Neurological Exams:

    • Nerve conduction studies (for CIDP/GBS)

  3. Hematological Workup:

    • Complete blood count (CBC)

    • Coagulation studies

  4. Renal/Liver Function Tests:

    • Creatinine clearance, eGFR, ALT/AST

IVIG Dosing Fundamentals

Dosing is weight-based and condition-specific:

Standard Dosing Guidelines

ConditionDoseFrequencyImmunodeficiency0.3–0.6 g/kgEvery 3–4 weeksITP1–2 g/kgSingle dose or split over 2–5 daysCIDP2 g/kg (loading), then 1 g/kgEvery 3 weeksGBS2 g/kgOver 5 days

Factors Influencing Dose Adjustments

  • Weight: Higher doses for obesity (adjusted body weight)

  • Renal Function: Reduce dose if eGFR <60 mL/min

  • Age: Geriatric patients often require slower infusions

  • Prior Reactions: Pre-medication for infusion-related reactions

How the IVIG Dose Calculator Works

Our IVIG Dose Calculator simplifies complex dosing calculations:

Input Parameters

  1. Patient Demographics:

    • Age, weight (with kg/lbs toggle)

    • Height (for BMI assessment)

  2. Clinical Data:

    • Primary diagnosis

    • Renal/liver function

    • Allergies (e.g., IgA deficiency)

  3. IVIG Protocol:

    • Product concentration (5% vs. 10%)

    • Target dose (g/kg)

    • Infusion duration

Calculation Algorithm

Total Dose (g) = Weight (kg) × Target Dose (g/kg) × Adjustment Factor

Adjustment factors account for age, renal function, and diagnosis.

Sample Output

  • Recommended Dose: 40 g

  • Infusion Volume: 800 mL (for 5% solution)

  • Infusion Rate: 200 mL/hr over 4 hours

  • Risk Assessment:

    • Low Risk: Stable vitals, no comorbidities

    • ⚠️ Moderate Risk: Renal impairment, elderly

    • High Risk: History of thrombosis, heart failure

Interpreting Calculator Results

1. Dose Recommendations

  • Immunodeficiency: Lower maintenance doses (0.3–0.6 g/kg)

  • Acute Conditions (ITP/GBS): High "rescue" doses (1–2 g/kg)

2. Risk Stratification

Risk LevelClinical ContextGreen (Low)Healthy patient, first infusionYellow (Moderate)Hypertension, mild renal impairmentRed (High)History of stroke, hyperviscosity

3. Personalized Guidance

  • Pre-medications: Acetaminophen + antihistamines

  • Hydration Protocol: 500 mL saline pre-/post-infusion

  • Monitoring: Vital signs every 30 minutes

Treatment Protocols & Administration

Step-by-Step Infusion Process

  1. Pre-treatment:

    • Hydrate with 0.9% saline

    • Administer pre-medications 30 mins prior

  2. Infusion Phases:

    • Initial Rate: 0.5 mg/kg/min

    • Gradual Escalation: Increase by 0.3 mg/kg/min every 15–30 mins

    • Max Rate: 8 mg/kg/min (per product guidelines)

  3. Post-infusion Monitoring:

    • Observe for 1 hour after completion

    • Assess for delayed reactions (headache, fever)

Potential Side Effects & Management

Common Reactions (10–30% of patients)

  • Mild: Headache, flushing, chills (managed with NSAIDs)

  • Moderate: Hypertension, tachycardia (slow infusion rate)

  • Severe (<5%):

    • Anaphylaxis (treat with epinephrine)

    • Thromboembolism (avoid in hypercoagulable states)

    • Renal Failure (use sucrose-free products)

Contraindications

  • Absolute: IgA deficiency with anti-IgA antibodies

  • Relative: Heart failure, renal impairment, thrombosis history

Alternative Therapies

When IVIG is unsuitable, consider:

  1. Subcutaneous IG (SCIG):

    • Home-based, lower side effects

    • Steady IgG levels

  2. Immunosuppressants:

    • Rituximab (for autoimmune disorders)

    • Corticosteroids (short-term use)

  3. Plasmapheresis:

    • First-line for GBS/CIDP crises

People Also Ask: Key FAQs

Q: How long does IVIG stay in your system?

A: IgG has a half-life of 21–28 days. Effects last 3–6 months.

Q: Why is IVIG dosed by weight?

A: Antibody distribution correlates with lean body mass. Weight-based dosing ensures therapeutic levels.

Q: Can IVIG cure autoimmune diseases?

A: No—it manages symptoms but isn’t curative. Maintenance therapy is often needed.

Q: What blood tests monitor IVIG safety?

A: Pre/post-infusion tests:

  • Creatinine (renal function)

  • Hemoglobin (hemolysis)

  • Viscosity (for thrombotic risk)

Conclusion: Optimizing IVIG Therapy

Precision dosing is the cornerstone of effective IVIG treatment. Our IVIG Dose Calculator integrates clinical guidelines with patient-specific factors to generate tailored protocols, minimizing risks while maximizing efficacy. By accounting for weight, diagnosis, and comorbidities, clinicians can confidently administer this life-changing therapy.

Disclaimer

This calculator provides estimates only. Actual IVIG dosing decisions should be made by qualified healthcare professionals considering complete clinical context. Results should not replace clinical judgment.